Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferntial effect on Th1 cells that is augmented by IL-4

International Immunology

Volumn 13, Issue 9, 2001, Pages 1109-1120

  Tran, Giang T ^a   Carter, Nicole ^a   He, Xiao Y ^a   Spicer, Timothy S ^a   Plain, Karen M ^a   Nicolls, Mark ^b   Hall, Bruce M ^a   Hodgkinson, Suzanne J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Anti CD3; Autoimmunity; Experimental allergic encephalomyelitis; Immunotherapy; Multiple sclerosis; Neuroimmunology; Regulatory T cells; Th1 Th2

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; MONOCLONAL ANTIBODY MRC OX 81; RECOMBINANT INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BRAIN STEM; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; DRUG EFFICACY; EFFECTOR CELL; FEMALE; IMMUNIZATION; INFLAMMATION; LYMPH NODE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0034802139     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/13.9.1109     Document Type: Article

References (60)

1. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis
2. Chronic relapsing experimental allergic encephalomyelitis: An experimental model of multiple sclerosis
3. Chemical studies on an encephalitogenic protein from guinea pig brain
4. T cell specificity for class II (I-A) and the encephalitogenic N terminal epitope of the autoantigen myelin basic protein
5. Encephalitogenic epitopes of myelin basic protein
6. - T lymphocytes
7. T cell immunity and interferon-gamma secretion during experimental allergic encephalomyelitis in Lewis rats
8. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: Dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor and tumor necrosis factor beta
9. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production
10. The mechanism of inhibition of experimental allergic encephalomyelitis in the rat by monoclonal antibody against CD4
11. In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis
12. Anti-CD4 Therapy: From Treatment of Experimental Allergic Encephalomyelitis to Clinical Trails in Multiple Sclerosis
13. Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis
14. Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis
15. Prevention and treatment of Lewis rat experimental allergic encephalomyelitis with a monoclonal antibody to the T cell receptor V beta 8. 2 segment
16. Effect of anti-interferon gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains
17. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis
18. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
19. Regulation of experimental autoimmune encephalomyelitis by interleukin-12
20. h2) immune response against non self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis
21. H2 cells: Different patterns of lymphokine secretion lead to different functional properties
22. Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype
23. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice
24. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL 4-deficient C57BL/6 mice and BALB/c mice
25. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity
26. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease
27. Experimental autoimmune encephalomyelitis in IL-4-deficient mice
28. h2) cells cause experimental allergic encephalomyelitis in immunodeficient hosts rather than protecting them from disease
29. h3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis
30. + T-cell inhibits antigen specific T-cell responses and prevents colitis
31. + T cells
32. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
33. Decreased CD3-mediated interferon-gamma production in relapsing remitting multiple sclerosis
34. A randomized clinical trial of induction therapy with OKT3 in kidney transplantation
35. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation
36. + T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta
37. A non-activating 'humanized' anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo
38. Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy
39. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells
40. H2 cytokines not anergy
41. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody
42. h2 clones
43. In vivo T lymphocyte activation induced in mice following the injection of anti-CD3 monoclonal antibody
44. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody
45. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice
46. Rat interleukin-4 assays
47. A monoclonal antibody (A6) recognizing a unique epitope restricted to CD45RO and RB isoforms of the leukocyte common antigen family identifies functional T cell subsets
48. + suppressor T cells that are not dependent upon IL-4
49. Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats
50. h1 like lymphokine profile: Cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis
51. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses
52. Cloning and expression of interleukin-5 from rats
53. h1 and cytotoxic cells in glomeruli
54. H2 cytokines
55. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
56. h2 cells
57. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats
58. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery
59. h subsets
60. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice